MedTrace Logo

Fertility Preservation in Female Cancer Patients

NCT01268592 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2013-04-23

No results posted yet for this study

Summary

The purpose of this study is to preserve the fertility potential in females diagnosed with cancer by vitrifying (rapidly freezing) their oocytes (eggs) before undergoing treatment for their cancer.

Conditions

Interventions

PROCEDURE

oocyte vitrification

freezing of the patient's retrieved oocytes via vitrification (rapid freezing)

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Avner Hershlag, MD · Center for Human Reproduction

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01268592 on ClinicalTrials.gov